Published in Antimicrob Agents Chemother on November 01, 2000
Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection. J Pharm Biomed Anal (2011) 2.10
Differential extracellular and intracellular concentrations of zidovudine and lamivudine in semen and plasma of HIV-1-infected men. J Acquir Immune Defic Syndr (2008) 1.02
DPC 817: a cytidine nucleoside analog with activity against zidovudine- and lamivudine-resistant viral variants. Antimicrob Agents Chemother (2002) 1.01
Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation. Antimicrob Agents Chemother (2003) 0.99
Effect of ribavirin on intracellular and plasma pharmacokinetics of nucleoside reverse transcriptase inhibitors in patients with human immunodeficiency virus-hepatitis C virus coinfection: results of a randomized clinical study. Antimicrob Agents Chemother (2005) 0.93
Development of enzymatic assays for quantification of intracellular lamivudine and carbovir triphosphate levels in peripheral blood mononuclear cells from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2002) 0.89
Zidovudine and Lamivudine for HIV Infection. Clin Med Rev Ther (2010) 0.89
Development of an optimized dose for coformulation of zidovudine with drugs that select for the K65R mutation using a population pharmacokinetic and enzyme kinetic simulation model. Antimicrob Agents Chemother (2008) 0.87
Intracellular pharmacokinetics of once versus twice daily zidovudine and lamivudine in adolescents. Antimicrob Agents Chemother (2007) 0.87
Lack of evidence for in vivo transformation of zidovudine triphosphate to stavudine triphosphate in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (2006) 0.84
Enzymatic assay for measurement of intracellular DXG triphosphate concentrations in peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother (2003) 0.82
HPLC-MS/MS method for the intracellular determination of ribavirin monophosphate and ribavirin triphosphate in CEM ss cells. J Pharm Biomed Anal (2009) 0.81
K65R-associated virologic failure in HIV-infected patients receiving tenofovir-containing triple nucleoside/nucleotide reverse transcriptase inhibitor regimens. MedGenMed (2004) 0.79
Is stavudine triphosphate a natural metabolite of zidovudine? Antimicrob Agents Chemother (2006) 0.79
Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine. Antimicrob Agents Chemother (2012) 0.79
Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells. Antimicrob Agents Chemother (2015) 0.75
Determination of ddATP levels in human immunodeficiency virus-infected patients treated with dideoxyinosine. Antimicrob Agents Chemother (2004) 0.75
A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med (1997) 17.51
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med (1997) 10.62
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci U S A (1986) 8.48
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. CMAJ (1999) 3.35
3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. Antimicrob Agents Chemother (1987) 2.60
Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma. Antimicrob Agents Chemother (1992) 2.15
The pharmacokinetics of lamivudine phosphorylation in peripheral blood mononuclear cells from patients infected with HIV-1. AIDS (1999) 1.78
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up. JAMA (1998) 1.59
Cellular metabolism of (-) enantiomeric 2'-deoxy-3'-thiacytidine. Biochem Pharmacol (1992) 1.57
The in vitro and in vivo anti-retrovirus activity, and intracellular metabolism of 3'-azido-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly dependent on the cell species. Biochem Pharmacol (1988) 1.45
Intracellular zidovudine (ZDV) and ZDV phosphates as measured by a validated combined high-pressure liquid chromatography-radioimmunoassay procedure. Antimicrob Agents Chemother (1992) 1.29
A method for the quantification of intracellular zidovudine nucleotides. J Infect Dis (1991) 1.24
Concentration-controlled zidovudine therapy. Clin Pharmacol Ther (1998) 1.20
Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1998) 1.11
Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cells. Antimicrob Agents Chemother (1994) 1.08
A sensitive nonisotopic method for the determination of intracellular azidothymidine 5'-mono-, 5'-di-, and 5'-triphosphate. Anal Biochem (1991) 1.08
Zidovudine response relationships in early human immunodeficiency virus infection. Clin Pharmacol Ther (1993) 1.05
Quantitation of intracellular zidovudine phosphates by use of combined cartridge-radioimmunoassay methodology. Antimicrob Agents Chemother (1996) 1.03
Intracellular nucleotides of (-)-2',3'-deoxy-3'-thiacytidine in peripheral blood mononuclear cells of a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother (1998) 1.00
Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections. AIDS (1998) 0.92
Quantification of zidovudine and individual zidovudine phosphates in peripheral blood mononuclear cells by a combined isocratic high performance liquid chromatography radioimmunoassay method. J Pharm Biomed Anal (1996) 0.92
Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomed Pharmacother (1999) 0.89
Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry. Antimicrob Agents Chemother (1999) 0.86
Treatment with lamivudine, zidovudine, or both in HIV-positive patients with 200 to 500 CD4+ cells per cubic millimeter. North American HIV Working Party. N Engl J Med (1995) 3.86
Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med (1982) 3.24
Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect (2000) 2.60
Early experience with adult extracorporeal membrane oxygenation in the modern era. Ann Thorac Surg (1992) 2.54
Engineering metal organic frameworks for heterogeneous catalysis. Chem Rev (2010) 2.53
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Breast US in children and adolescents. Radiographics (2001) 1.45
Effect of triglycyl-lysine-vasopressin on skin blood flow and blood loss during wound excision in patients with burns. J Burn Care Rehabil (1993) 1.39
Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate. Infect Immun (1999) 1.31
Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg (1994) 1.31
Mechanism of decreased in vitro murine macrophage cytokine release after exposure to carbon dioxide: relevance to laparoscopic surgery. Ann Surg (1997) 1.24
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Socio-economic inequalities in the prevalence of Type 2 diabetes, cardiovascular risk factors and chronic diabetic complications in the Basque Country, Spain. Diabet Med (2005) 1.22
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Lymphocyte subset responses to trauma and sepsis. J Trauma (1993) 1.19
Early versus late tracheostomy in the trauma patient. Respir Care Clin N Am (1997) 1.16
Anaphylaxis after ingestion of beignets contaminated with Dermatophagoides farinae. J Allergy Clin Immunol (1993) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts. J Invest Dermatol (1993) 1.07
A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am J Surg (1992) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Consequences of high-dose steroid therapy for acute spinal cord injury. J Trauma (1997) 1.06
A comparison of bronchodilator responses to albuterol delivered by ultrasonic versus jet nebulization in moderate to severe asthma. Ann Allergy Asthma Immunol (1996) 1.06
Abdominal vena caval injuries: outcomes remain dismal. Surgery (2000) 1.06
Cyclosporin A inhibits degranulation of rat basophilic leukemia cells and human basophils. Inhibition of mediator release without affecting PI hydrolysis or Ca2+ fluxes. J Immunol (1990) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
Macrophage TNF secretion in endotoxin tolerance: role of SAPK, p38, and MAPK. J Surg Res (1999) 1.01
Initial experience with laparoscopic live donor nephrectomy. Surgery (1999) 1.00
Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains. Arch Med Res (1996) 1.00
Incidence, prevalence and coronary heart disease risk level in known Type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia (2003) 0.99
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99
Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97
Laser flash photolysis study of Jacobsen catalyst and related manganese(III) salen complexes. Relevance to catalysis. J Am Chem Soc (2001) 0.95
Measurement of associated production of vector bosons and top quark-antiquark pairs in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2013) 0.95
Search for dark matter and large extra dimensions in pp collisions yielding a photon and missing transverse energy. Phys Rev Lett (2012) 0.95
Characterization of the antigen reactive with anti-Scl-70 antibodies and its application in an enzyme-linked immunosorbent assay. Arthritis Rheum (1988) 0.94
In vivo endotoxin tolerance: impaired LPS-stimulated TNF release of monocytes from patients with sepsis, but not SIRS. J Surg Res (1997) 0.94
Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify "septic" intensive care unit patients. Shock (2000) 0.94
Posttrauma thromboembolism prophylaxis. J Trauma (1997) 0.94
Intracellular studies of the nucleoside reverse transcriptase inhibitor active metabolites: a review. P R Health Sci J (2000) 0.92
Trauma in cirrhotics: survival and hospital sequelae in patients requiring abdominal exploration. Am Surg (2000) 0.92
Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol (1988) 0.92
Y chromosome sequences in Turner's syndrome: association with virilization and gonadoblastoma. J Pediatr Endocrinol Metab (2003) 0.92
Carotenoids and antioxidant vitamins in patients after burn injury. J Burn Care Rehabil (1997) 0.91
First measurement of Bose-Einstein correlations in proton-proton collisions at √s=0.9 and 2.36 TeV at the LHC. Phys Rev Lett (2010) 0.91
Search for supersymmetry in pp collisions at √7 TeV in events with two photons and missing transverse energy. Phys Rev Lett (2011) 0.90
Psychosocial factors limit outcomes after trauma. J Trauma (1998) 0.89
Volatile anesthetic modulation of lung injury and outcome in a murine model of multiple organ dysfunction syndrome. Shock (1995) 0.88
Linear IgA bullous dermatosis associated with Hodgkin's disease. J Am Acad Dermatol (1988) 0.88
Clinical evaluation of Pharmacia CAP System RAST FEIA amoxicilloyl and benzylpenicilloyl in patients with penicillin allergy. Allergy (2001) 0.88
Cytokines and the pathogenesis of nosocomial pneumonia. Surgery (2001) 0.87
Pulmonary nocardiosis in the acquired immunodeficiency syndrome. Diagnosis with bronchoalveolar lavage and treatment with non-sulphur containing drugs. Chest (1986) 0.87
Impaired mitogen-activated protein kinase activation and altered cytokine secretion in endotoxin-tolerant human monocytes. J Trauma (2000) 0.86
[Acute interstitial nephritis associated with omeprazole therapy]. Nefrologia (2004) 0.86
Search for pair production of second-generation scalar leptoquarks in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.86
Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry. Antimicrob Agents Chemother (1999) 0.86
A 2.4 GHz ULP OOK Single-Chip Transceiver for Healthcare Applications. IEEE Trans Biomed Circuits Syst (2011) 0.86
p16(INK4a) gene alterations are frequent in lesions of mycosis fungoides. Am J Pathol (2000) 0.86
Measurement of the B(+) production cross section in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2011) 0.86
Local control with pre-operative radiotherapy alone versus "sandwich" radiotherapy for rectal carcinoma. Int J Radiat Oncol Biol Phys (1987) 0.86
Ordered transcriptional factor recruitment and epigenetic regulation of tnf-alpha in necrotizing acute pancreatitis. Cell Mol Life Sci (2010) 0.85
Trauma faculty and trauma team activation: impact on trauma system function and patient outcome. J Trauma (1999) 0.85
Measurement of the B0 production cross section in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2011) 0.85
A new rapid and more sensitive microcytotoxicity test. J Immunol Methods (1972) 0.85
Search for three-jet resonances in pp collisions at square root(s)=7 TeV. Phys Rev Lett (2011) 0.85
Acute skin injury releases neutrophil chemoattractants. Surgery (1994) 0.85
Optimization of a novel method for the organic chemical characterization of atmospheric aerosols based on microwave-assisted extraction combined with stir bar sorptive extraction. Anal Chim Acta (2007) 0.85
Observation of sequential Υ suppression in PbPb collisions. Phys Rev Lett (2012) 0.84
Filariasis in Colombia: prevalence and distribution of Mansonella ozzardi and Mansonella (=Dipetalonema) perstans infections in the Comisaría del Guainía. Am J Trop Med Hyg (1983) 0.84
Vomiting and regurgitation. Clin Gastroenterol (1977) 0.84
Percutaneous treatment of a traumatic aortic dissection by balloon fenestration and stent placement. AJR Am J Roentgenol (1995) 0.84
Acetazolamide treatment prevents in vitro endotoxin-stimulated tumor necrosis factor release in mouse macrophages. Shock (1998) 0.84
Wound management in perforated appendicitis. Am Surg (1999) 0.83
Multiple organ dysfunction syndrome: end organ and systemic inflammatory response in a mouse model of nonseptic origin. Shock (1995) 0.83
Traumatic rupture of a cervical parathyroid adenoma. Surgery (1994) 0.82
Inhibitory kappaBalpha control of nuclear factor-kappaB is dysregulated in endotoxin tolerant macrophages. Shock (1999) 0.82
Involvement of calyculin A-sensitive phosphatase(s) in the differentiation of Trypanosoma cruzi trypomastigotes to amastigotes. Mol Biochem Parasitol (1999) 0.82
Pneumocystis carinii pneumonia presenting as cavitating and noncavitating solitary pulmonary nodules in patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis (1986) 0.82
Biliary tract injury following blunt abdominal trauma: case reports. J Trauma (1995) 0.82
Coincident multiple myeloma and non-Hodgkin's lymphoma with 2 serum monoclonal immunoglobulins. Acta Haematol (1986) 0.82
Survival and vertical distribution of larvae of Culicoides variipennis (Diptera: Ceratopogonidae) in drying mud habitats. J Med Entomol (1992) 0.82
Salmonella Paratyphi B var Java infections associated with exposure to turtles in Bizkaia, Spain, September 2010 to October 2011. Euro Surveill (2012) 0.81
Measurement of the CP violation parameter sin2 phi(1) in B(0)(d) meson decays. Phys Rev Lett (2001) 0.81
Hypertrophic scar fibroblasts accelerate collagen gel contraction. Wound Repair Regen (2006) 0.81
Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi. Eur J Med Chem (2000) 0.81
Fluid composition from implanted perforated capsules: an approach to interstitial fluid? J Appl Physiol (1972) 0.81
Toxic evaluation of organic extracts from airborne particulate matter in Puerto Rico. Environ Health Perspect (2000) 0.81
Study of Z Boson Production in PbPb Collisions at √S(NN)=2.76 TeV. Phys Rev Lett (2011) 0.81
Ulceronecrotic lesions in a patient with essential thrombocythaemia. Clin Exp Dermatol (1991) 0.81